Covid-19 Infection Predisposing Endocarditis Complicated by the Challenges of Patient Care in a Pandemic

Management of Infective Endocarditis and Tibioperoneal Mycotic Aneurysm Following COVID-19 Infection

“…Peripheral embolic complications have been reported in nine other cases ( Table 1 ) of COVID-19 associated infective endocarditis. 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 Peripheral mycotic aneurysms are rare but serious complications of infective endocarditis. They may suddenly become symptomatic, usually from acute rupture, or develop a more gradual course, as in the current patient.…”

“…(2021) 13 50/M Fever, confusion, dyspnoea Aortic valve Staphylococcus aureus Left foot ischaemia, L5–S1 discitis Flucloxacillin for six weeks Left forefoot amputation Discharged Lowell et al. (2021) 14 59/M Fever and abdominal cramps Mitral valve Streptococcus agalactiae Splenic infarct Ceftriaxone Mitral valve replacement Discharged Sakata et al. 2022 15 34/F Fever, cough, chest pain Mitral valve Staphylococcus aureus Left circumflex coronary branch occlusion, right renal artery occlusion, cerebral infarct Vancomycin, cefazolin Mitral valve replacement Discharge day 25 Taghizadeh-Waghefi et al.…”